Equities

Cryofocus Medtech Shanghai Co Ltd

Cryofocus Medtech Shanghai Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)7.55
  • Today's Change-0.01 / -0.13%
  • Shares traded13.00k
  • 1 Year change-54.52%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments103226158
Total Receivables, Net(0.49)(0.27)0.10
Total Inventory423421
Prepaid expenses------
Other current assets, total4.514.4411
Total current assets150264189
Property, plant & equipment, net514238
Goodwill, net------
Intangibles, net0.020.040.06
Long term investments------
Note receivable - long term------
Other long term assets9.196.984.05
Total assets213314232
LIABILITIES
Accounts payable0.911.760.31
Accrued expenses243722
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.253.432.60
Other current liabilities, total2.883.792.91
Total current liabilities314628
Total long term debt7.767.946.41
Total debt11119.00
Deferred income tax------
Minority interest122026
Other liabilities, total0.820.800
Total liabilities517561
SHAREHOLDERS EQUITY
Common stock239239228
Additional paid-in capital300300151
Retained earnings (accumulated deficit)(377)(300)(208)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.09)(0.05)(0.07)
Total equity161239171
Total liabilities & shareholders' equity213314232
Total common shares outstanding239239239
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.